Novel and Emerging Targeted Therapies of Colorectal Cancer

被引：4
|
作者：
Finnberg, Niklas [1 ,2 ]
Gokare, Prashanth
El-Deiry, Wafik S.
机构：
[1] Fox Chase Canc Ctr, Lab Translat Oncol & Expt Canc Therapeut, Dept Med Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA
来源：
CURRENT CLINICAL PHARMACOLOGY | 2015年 / 10卷 / 04期
关键词：
Clinical; colorectal cancer; DPYD; RAS; targeted therapy; TRAIL;
D O I：
10.2174/1574884710666151020095911
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The survival rate of patients with colorectal cancer (CRC) is steadily increasing over the past decade. However, CRC continue to be one of the leading causes of cancer-related fatality in the United States. Current targeted strategies offer limited clinical benefits and the overall survival rate for CRC remains low. Improved understanding of the molecular changes associated with CRC that control growth factor signaling and evasion of cell death allow for the development of improved targeted therapy. This review aims to discuss some of the emerging therapies aimed to target CRC.
引用
收藏
页码：279 / 298
页数：20
相关论文
共 50 条
  • [41] Novel targeted therapies for metastatic breast cancer
    Jazieh, Khalid
    Bell, Ruth
    Agarwal, Nayan
    Abraham, Jame
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (14)
  • [42] Emerging novel therapies for advanced prostate cancer
    Osanto, Susanne
    Van Poppel, Hendrik
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (01) : 3 - 12
  • [43] MicroRNAs: Emerging Novel Targets of Cancer Therapies
    Yang, Chengfeng
    Jiang, Yiguo
    Singh, Ajay P.
    Takeshita, Fumitaka
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [44] Emerging targeted therapies for melanoma
    Johnson, Douglas B.
    Pollack, Megan H.
    Sosman, Jeffrey A.
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (02) : 195 - 207
  • [45] Emerging targeted therapies for glioma
    Miller, Julie J.
    Wen, Patrick Y.
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (04) : 441 - 452
  • [46] Emerging targeted therapies in myelofibrosis
    Barosi, Giovanni
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (03) : 313 - 324
  • [47] Emerging targeted therapies in triple-negative breast cancer
    Crown, J.
    O'Shaughnessy, J.
    Gullo, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 56 - 65
  • [48] Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer
    Patel, Jesal C.
    Maughan, Benjamin L.
    Agarwal, ArchanaM.
    Batten, Julia A.
    Zhang, Tian Y.
    Agarwal, Neeraj
    PROSTATE CANCER, 2013, 2013
  • [49] Telomere-Based Cancer Treatment: Emerging Targeted Therapies
    Chen, Michele
    McLeskey, Sandra W.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2010, 14 (06) : 720 - 726
  • [50] Emerging molecular targeted therapies in the treatment of head and neck cancer
    Bozec, Alexandre
    Peyrade, Frederic
    Fischel, Jean-Louis
    Milano, Gerard
    EXPERT OPINION ON EMERGING DRUGS, 2009, 14 (02) : 299 - 310
12345